Adami HO, Bergström R, Sparen P, Baron J: Increasing cancer risk in younger birth cohorts in Sweden. Lancet 341: 773-7; 1993
Adami HO, Trichopoulos D: Obesity and mortality from cancer. New Engl J Med 348: 1623-4; 2003 Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E: Estrogen
metabolism and excretion in oriental and caucasian women. J Natl Cancer Inst 86: 1076-82; 1994
Adlkofer F, Rüdiger H, Wobus A: DNA-Doppelstrangbrüche bei intermittierender Exposition. Diskus- sionsbeitrag. Dt Ärztebl 99/46: B2632-3; 2002
Ahlborg UG, Lipworth L, Titus-Ernstoff L: Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25: 463-531; 1995
Akkan Z, Flaig H, Ballschmiter KH: Pflanzenbehandlungs- und Schädlingsbekämpfungsmittel in der Umwelt – Emissionen, Immissionen und ihre human- und ökotoxikologische Bewertung. E. Schmidt Verlag Berlin, 11-281; 2003
Althuis MD, Brogan DR, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JE, Brinton LA: Hormonal content and potency of oral contraceptives and breast cancer risk among young women. Br J Cancer 88/1: 50-7; 2003
Alvarez L, Randi A, Alvarez P, Proli G, Chamson-Reig A, Lux-Lantos V, Kleiman de Pisarev D: Reproductive effects of hexachlorobenzene in female rats. J Appl Toxicol 20/1: 81-7; 2000 Andersen A, Barlow L, Engeland A, Kjaerheim K, Lynge E, Pukkala E: Work-relates cancer in the
Nordic countries. Scand J Work Environ Health 25 Suppl 2: 1-116; 1999
Anonym: News: Studies link familial breast, prostate cancers. J Natl Cancer Inst 85:776; 1993 Anonym: Ovarian ablation in early breast cancer: overview of the randomised trials. Early breast cancer trialists colloborative Group. Lancet 348: 1189-96; 1996
Appel KE: Zur kanzerogenen Wirkung von Pentachlorphenol. Bundesgesundhbl 37/8: 334-41; 1994 Appel KE, Gericke S: Zur Neurotoxizität und Toxikokinetik von Pyrethroiden. Bundesgesundhbl 42:
219-28; 1993
Arbeitsgemeinschaft bevölkerungsbezogener Krebsregister in Deutschland: Krebs in Deutschland. www.rki.de/KREBS; Saarbrücken 3. erweiterte, aktualisierte Ausgabe, 48-52; 2002
Archibeque-Engle S, Tessari JD, Winn DT: Quality assurance/quality control procedures for chlorinated hydrocarbons in human breast adipose tissue. Journal of Toxicology and Environmental Health, 49: 589-598, 1996
Archibeque-Engle S, Tessari JD, Winn DT, Keefe TJ, Nett TM, Zheng T: Comparison of organochlorine pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum. J Toxicol Environ Health 52/4: 285-93; 1997
Ardies CM, Dees C: Xenoestrogens significantly enhance risk for breast cancer during growth and adolescence. Med Hypothesis 50/6: 457-64; 1998
Armstrong B, Woodings T, Stenhouse N.: Mortality from cancer in migrants to Australia 1962-71. In: Nedlands WA (Hrsg.): NH&MRSC Research Unit in Epidemiology and Preventive Medicine, University of Western Australia, Australia, 1983
Armstrong K, Eisen A, Weber B: Assessing the risk of breast cancer. New Engl J Med 342: 564-71; 2000
Arnold SF, Klotz D, Collins B, Vonier PM, Guillette LJ jr, McLachlan JA: Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272: 1489-92; 1996 Arnold SF, Vonier PM, Collins BM, Klotz DM, Guillette LJ jr, McLachlan JA: In vitro synergistic
interaction of alligator and human estrogen receptors with combinations of environmental chemicals. Environ Health Perspect 105/Suppl 3: 615-8; 1997
Arnot B: Das Anti-Brustkrebs-Buch - Vorbeugung durch richtige Ernährung und Lebensweise. Piper Verlag München; 1-275; 2002
Aronson KJ, Miller AB, Woolcott CG, Sterns EE, McCready DR, Lickley LA, Fish EB, Hiraki GY, Holloway C, Ross T, Hanna WM, SenGupta SK, Weber JP: Breat adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epid. Biomarkers & Prevention 9: 55-63; 2000
Asplund L, Svensson BG, Nilsson A, Eriksson U, Jansson B: Polychlorinated biphenyls, p,p-DDT and p,p-DDE in human plasma related to fish consumption. Arch Environ Health 49/6: 477-86; 1994
Austin H, Keil JE, Cole P: A prospective follow-up study of cancer mortality in relation to serum DDT. Am J Public Health 79/1: 43-6; 1989
Axelson O: A review of porphyria and cancer and the missing link with human exposure to hexachlorobenzene. IARC Sci Publ 77: 585-89; 1986
Bagga D, Anders KH, Wang HJ, Roberts E, Glaspy JA: Organochlorine pesticide content of breast adipose tissue from women with breast cancer and control subjects. J Natl Cancer Inst 92/9: 750-3; 2000
Ballschmiter K, Zell M: Analysis of polychlorinated biphenyls (PCB) by glass capillary gas chromatography. Composition of technical Arochlor and Clophen PCB mixtures. Fresenius Z Anal Chem 302: 20-31; 1980
Baltzer J, Mickan H: Gynäkologie. Ein Lehrbuch. Georg Thieme Verlag Stuttgart-New York 1994 Band PR, Le ND, Fang R, Deschamps M, Gallagher RP, Yang P: Identification of occupation cancer
risks in British Columbia: a population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med 42: 284- 310; 2000
Band PR, Le ND, Fang R, Deschamps M: Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 360:1044-49; 2002
Barrett JC: Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Env Health Perspect 100:9-20; 1993
Barrueco C, Herrera A, Caballo C, de la Pena E: Induction of structural chromosome aberrations in human lymphocyte cultures and CHO cells by permethrin. Teratog Carcinog Mutagen 14/1: 31- 8; 1994
Bassermann K: Der Markt für Pflanzenschutzmittel. Dissertation Universität Hohenheim 1999
Bauchinger M, Dresp J, Schmid E, Hauf R: Chromosome changes in lymphocytes after occupational exposure to pentachlorphenol (PCP). Mut Res 102: 83-88; 1982
Baum M, Ziv Y, Colletta AA: Can we prevent breast cancer? Br J Cancer 64:205-07; 1991
Beatson G: On the treatment of not operable cases of carcinoma of the mamma: suggestions from a new method with illustrative cases. Lancet ii: 104-7; 1896
Beck H, Alder L, Mathar W, Palavinskas R: PCDDs, PCDFs, PCBs and other organochlorine compounds in human milk levels and their dynamics in Germany. Organohalogen Compounds 21: 39-44; 1994
Becker K, Kraus S, Krause C: Umwelt-Survey 1998, Band III: Human-Biomonitoring. Stoffgehalte im Blut und Urin der Bevölkerung in Deutschland. WaBoLu-Heft 1/02, Umweltbundesamt, Eigenverlag, Berlin 2002
Bell EM, Hertz-Picciotto I, Beaumont JJ: A case-control study of pesticides and fetal death due to congenital anomalies. Epidemiology 12/148-56; 2001
Bennicke K, Conrad C, Sabroe S, Sorensen HA: Cigarette smoking and breast cancer. Br Med J 310: 1431-33; 1995
Bernhardt JH: Gesundheitliche Aspekte niederfrequenter Felder der Stromversorgung. Dt Ärztebl 99/27: B 1008-13; 2002
Beral V; Million Women Study Collaborators: Breast cancer and hormone replacement therapy in the Millon Women Study. Lancet 362: 419-27; 2003.
Bertram HP, Kemper FH, Müller C: Hexachlorobenzene content in human whole blood and adipose tissue: Experiences in environmental specimen banking. IARC Sci Publ 77:173-82; 1986
Bercovici B, Wassermann M, Cucos S, Ron M, Wassermann D, Pines A: Serum level of polychlorinated biphenyl and some organochlorine insecticides in women with recent and former missed abortion. Environ Res 30: 169-174; 1983
Bertz J: Vergleich der Krebssterblichkeit in den alten Bundesländern der Bundesrepublik Deutschland und der ehemaligen DDR. Schriftenreihe des Institutes für Sozialmedizin und Epidemiologie des Bundesgesundheitsamtes, Berlin Band 5: 1991.
Bevers TB: Primary Prevention and early detection. In: Breast cancer. Hrsg.: Hunt K et al. Springer Verlag New York, 121-34; 2001
Beyer A, Eis D: Praktische Umweltmedizin: Klinik, Methoden, Arbeitshilfen, Springer Verlag Berlin Heidelberg New York; 1994
Bigsby RM, Steinmetz R: Organochlorine residues and breast cancer. Correspondence. New Engl J Med 338: 990; 1998
Bigsby RM, Caperell-Grant A, Madhukar BV: Xenobiotics released from fat during fasting produce estrogenic effects in ovarectomized mice. Cancer research 57:865-69; 1997
Blackwood A, Wolff MS, Rundle A: Organochlorine compounds (DDE and PCB) in plasma and breast cyst fluid of women with benign breast disease. Cancer Epidemiol Biomarkers Prev 7/7:579-83; 1998
Blair A, Dosemeci M, Heineman EF: Cancer and other causes of death among male and female farmers from twenty-three states. Am J Ind Med 23: 729-742; 1993
Blohmke M: Morbidität bei berufstätigen Frauen in gewerblichen Berufen. Lebensversicherungs- medizin 2: 33-6; 1981
Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M et al.: Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/minerals combination, cancer incidence and disease-specific mortality in the general population. J Natl Cancer Inst 85:1483-92; 1993
Bock P: Zusammenhänge zwischen Bioziden und Brustkrebs. Inaugural-Dissertation. Frankfurt am Main 2001
Boice JD jr, Blettner M, Auvinen A: Epidemiologic studies of pilots and aircrew. Health Phys 79: 576-84; 2000
Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I: Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91/16: 1376-81; 1999
Boyle P: Epidemiology of breast cancer, Bailliere`s Clinical Oncolgy 2/1: 1-57; 1988
Bradford Hill A: The Environment and Disease: Association or Causation? Proc Royal Soc Med 58:295-300; 1965
Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari R: Effects of pesticides on the ratio of 16α/2- Hydroxyestrone: A biologic marker of breast cancer risk. Environ Health Perspect 103/Suppl 7: 147-50; 1995
Brandt M, Schmidt E, Schmidt FW: Chronische Lebererkrankungen durch langjährige Intoxikation im Haushalt mit Pentachlorphenol. Verh Dtsch Ges Inn Med 83: 1609-1611; 1977
Brauch H, Brüning T, Hamann U, Ko Y für die GENICA-Netzwerk interdisziplinäre Studien- gruppe (www.genica.de): persönliche Mitteilung 2004
Brenner H, Stegmaier C: Projektion des Effekts veränderter Fertilitätsraten auf die Brustkrebsinzidenz: Eine Studie aus dem Saarland. Soziale- und Präventivmedizin 35: 1-4; 1990
Brezner E, Terkel J, Perry AS: The effect of Arochlor 1254 (PCB) on the physiology of reproduction on the female rat. I Comp Biochem Physiol 77C: 65-70; 1984
Brinton LA, Daling JR, Liff JM, Schoenberg JB: Oral contraceptives and breast cancer risk among young women. J Natl Cancer Inst 87: 827-35; 1995
Brody JG, Rudel RA: Environmental pollutants and breast cancer. Environ Health Perspect 111: 1007-19; 2003
Bronstein I, Semendjajew K: Taschenbuch der Mathematik. Verlag Harry Deutsch, Frankfurt/Main 1987
Brophy JT, Keith MM, Gorey KM, Laukkanen E, Hellyer D, Watterson A, Reinhartz A, Gilberston M: Occupational histories of cancer patients in a Canadian cancer treatment center and the generated hypothesis regarding breast cancer and farming. Int J Occup Environ Health 8/4: 346-5; 2002
Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N: Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103: 608-12; 1995
Brown NM, Lamartiniere CA: Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ Health Perspect 103: 708-13; 1995
Bryan CP: Ancient Egyptian medicine in the papyrus Ebers. Ares Publishers Inc.: Chicago, Illinois: 162-67; 1930
Bucheli TD, Fent K: Induction of cytochrome P450 as a biomarker for environmental contamination in aquatic ecosystems. Crit Rev Environ Sci Tech 25/3: 201-68; 1995
Bulger W, Kupfer D: Estrogenic action of DDT analogs. Am J Ind Med 4:163-73; 1983
Bundesamt für Strahlenschutz: Qualitätsverbesserung ist entscheidend: Pressemitteilung vom 21.03.2003
Buranatrevedh S, Deodutta R: Occupational exposure to endocrin-disrupting pesticides and the potential for developing homonal cancers. J Environ Health 64/3: 17-29; 2001
Butler WH, Cohen SH, Squire RA: Mesenchymal tumors of the mouse urinary bladder with vascular and smooth muscle differentiation. Toxicol Pathol 25/3: 268-74; 1997
Cabral JR, Galendo D, Laval M, Lyandrat N: Carcinogenicity studies with deltamethrin in mice and rats. Cancer Lett 49/2: 147-52; 1990
Calle EE, Frumkin H, Henley SJ, Savitz DA, Thun MJ: Organochlorines and breast cancer risk. CA A Cancer Journal for Clinicians 52: 301-9; 2002
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity and mortality from cancer in a prospective studied cohort of U.S. adults. New Engl J Med 348:1625-38; 2003 Cantor K, Stewart P, Brinton L, Dosemeci M: Occupational exposures and female breast cancer
mortality in the United States. J Occup Environ Med 37/3: 336-348; 1995
Caplan LS, Schoenfeld ER, O`Leary ES, Leske MC: Breast cancer and electromagnetic fields- a review. Ann Epidemiol 10/1: 31-44; 2000
Carson R: Der stumme Frühling. C.H. Beck Verlag München: 222-46; 1990. Titel der Originalausgabe: Silent Spring. Penguine Books-Verlag England; 1962
Cassee FR, Groten JP, van Bladeren PJ, Feron VJ: Toxicological evaluation and risk assessment of chemical mixtures. Crit Rev Toxicol 28/1: 73-101; 1998
Cassidy A, Bingham S, Stechell KD: Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60: 333-40; 1994
Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR for the Osteoporotic fractures research group: Bone mineral density and risk of breast cancer in older women. JAMA 276: 611-7; 1996
Chang-Claude J, Scherneck S: Klonierung des Brustkrebsgens BRCA1. Dt Ärztebl 92/37: A2414-18; 1995
Charles MJ, Schell MJ, Willman E, Gross HB, Lin Y, Sonnenberg S: Organochlorines and 8- Hydroxy-2-Deoxyguanosine (8-OHdG) in Cancerous and non-cancerous breast tissue. Arch Environ Contam Toxicol 41: 386-95; 2001
Charles MJ: Persönliche Mitteilung 14.11.2002
Charlier C, Albert A, Herman P, Hamoir E, Gaspard U, Meurisse M, Plomteux G: Breast cancer and serum organochlorine residues. Occup Environ Med 60: 348-51; 2003
Chen CL, Weiss NS, Newcomb P, Barlow W, White E: Hormone replacement therapy in relation to breast cancer. JAMA 287/6: 734-41; 2002
Chen H, Xiao J, Hu G, Zhou J, Xiao H, Wang X: Estrogenicity of organophosphorus and pyrethroid pesticides. J Toxicol Environ Health A. 65: 1419-35; 2002
Chlebowski RT: Reducing the risk of breast cancer. Review article. New Engl J Med 343/3: 191-8; 2000
Cho E, Spiegelman D, Hunter DJ, Chen WY, Zhang SM, Colditz GA, Willett WC: Premenopausal intake of vitamines A, C, and E, folate, and carotenoids, and risk of breast cancer. Cancer Epid Biom & Prev 12: 713-20; 2003
Clarke R, Clarke-Hilakivi L, Cho E, James MR, Leonessa F: Estrogens, phytoestrogens and breast cancer. Advances in experimental medicine and biology 401: 63-85; 1996
Clemmesen J: Carcinoma of the breast. Results from statistical research. Br J Radiol 21:583-90; 1948
Clemons M, Goss P: Estrogen and the risk of breast cancer. Review article. New Engl J Med 344: 276-285; 2001
Cline JM, Sonderquvist G, von Schoultz E, Skoog L, von Schoultz A: Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am J Obstet Gynecol 174: 93-100; 1996
Cocco P: On the rumors about the silent spring. Review of the scientific evidence linking occupational and environmental pesticide exposure to endocrine disruption health effects. Cad. Saude Publica 18/2: 379-402; 2002
Cocco P, Kazerouni N, Zahm SH: Cancer mortality and environmental exposure to DDE in the United States. Environ Health Perspect 108/1: 1-4; 2000
Cohn BA, Cirillo PM, Wolff MS, Schwingl PJ, Cohen RD, Sholz RI: DDT and DDE exposure in mothers and time to pregnency in daughters. Lancet 361: 2205-6; 2003
Colborn T, Dumanoski D, Myers JP: Die bedrohte Zukunft: Gefährden wir unsere Fruchtbarkeit und Überlebensfähigkeit? Droemer Knaur Verlag München; 1996
Colditz GA: Epidemiology of breast cancer. Cancer 71: 1480-89; 1993
Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332: 1589- 93; 1995
Collins FS: BRCA1- lots of mutations, lots of dilemmas (Vorwort). N Engl J Med 334: 186-88; 1996 Colloborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormonal
contraceptives: colloborate reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713- 27; 1996
Colloborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacemant therapy: colloborate reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 350: 1047-59; 1997
Colloborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer:colloborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet 358:1389-99; 2001
Colloborative Group on Hormonal Factors in Breast Cancer: Alcohol, tobacco and breast cancer- colloborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease. Br J Cancer 87/11: 1234-45; 2002a
Colloborative Group on Hormonal Factors in Breast Cancer: Breast cancer and breastfeeding: colloborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360: 187-95; 2002b
Colosio C, Maroni M, Barcellini W, Meroni P, Alcini D, Colombi A, Cavallo D, Foa V: Toxicological and immune findings in workers exposed to pentachlorophenol (PCP). Arch Environ Health 48/2: 81-8; 1993
Colt JS, Stallones L, Cameron LL, Dosemeci M, Zahm SH: Proportionate mortality among US migrant and seasonal framworkers in twenty-four states. Am J Ind Med 40: 604-11; 2001
Costa A: Biological approaches to breast cancer prevention. The Breast 1: 119-23; 1992
Covaci A, de Boer J, Ryan JJ, Voorspoels S, Schepens P: Distribution of organobrominated and organochlorinated contaminants in Belgian human adipose tissue. Environ Res 88/3: 210-8; 2002
Crisp TM, Clegg ED, Cooper RL: Environmental endocrine disruption: An effects assessment and analysis. Environ Health Perspect 106 (Suppl1): 11-56; 1998
Cui J, Hopper JL: Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study. Cancer Epidem Biom & Prev 9: 805-12; 2000
Daniel V, Huber W, Bauer KD, Opelz G: Impaired in-vitro Lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health 50/4: 287-92; 1995
Danzo B: Environmental Xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ Health Perspect 105/3: 294-301; 1997
Danzo B, Shappell HW, Banerjee A, Hachey DL: Effects of nonylphenol, p,p-DDE, and Pentachlorophenol on the adult female guinea pig reproductive tract. Reprod Toxicol 16/1: 29- 43; 2002
Daunderer M: Handbuch der Umweltgifte: Klinische Umwelttoxikologie für die Praxis, Band III, ecomed-Verlag Landsberg/Lech; 1990
Davis DL, Bradlow HL, Wolff MS, Woodruff T, Hoel DG,Culver HA: Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101/5: 372- 77; 1993
Dees C, Askaari M, Foster J, Ahamed S, Wimalasena J: DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle. Molecular Carcinogenesis 18:107-114; 1997
Deichmann WB: The debate on DDT. Arch Toxicol 29: 1-27; 1972
Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-20; 1998 Dello Iacovo RD, Celentano E, Strollo AM, Iazzetta G, Capasso I, Randazzo G: Organochlorines
and breast cancer. A study on Neapolitan women. Adv Exp Med Biol 472: 57-66; 1999
Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E: Risk and Aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epid Biom Epid 9:161-6; 2000
Desaulniers D, Leingartner K, Russo J, Perkins G, Chittim BG, Archer MC, Wade M, Yang J: Modulatory effects of neonatal exposure to TCDD, or a mixture of PCBss, p,p-DDT, and p,p- DDE, on methylnitrosourea-induced mammary tumor development in the rat. Environ Health Perspect. 109/7: 739-47; 2001
Devesa SS: Recent cancer patterns among men and women in the United States: clues for occupational research. J Occup Med. 36: 832-41; 1994
De Waard F: Guest Editorial: Premenopausal and postmenopausal breast cancer: One disease or two? J Natl Cancer Inst 63/3: 549-52; 1979
Dewailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin J, Brisson J: High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86/3: 232- 34; 1994a
Dewailly E, Ayotte P, Brisson J, Dodin S: Breast cancer and organochlorines. Lancet 344: 1707-8; 1994b
Dewailly E, Ayotte P, Brisson J: Protective effect of breast feeding on breast cancer and body burden of carcinogenic organochlorines. Correspondence. J Natl Cancer Inst 86/10: 803; 1994c Dewailly E, Mulvad G, Pedersen HS, Ayotte P, Demers A, Weber JP, Hansen JC: Concentration of
organochlorines in human brain, liver, and adipose tissue autopsy samples from Greenland. Environ Health Perspect 107/10: 823-8; 1999
Dewailly E: Could the rising levels of estrogen receptor in breast cancer be due to estrogenic pollutants? Zuschrift. J Natl Cancer Inst 89/2: 888; 1997
DFG Deutsche Forschungsgemeinschaft: MAK- und BAT-Werte-Liste 2003. Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Wiley-VCH-Verlag Weinheim; Mitteilung 39: 123- 32; 2003
Dhodapkar MV, Ingle JN, Ahmann DL: Estrogen replacement therapy withdrawal and regression of